CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
intermittent positive-pressure breathingprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000565
NCT00000565Phase 3Completed
CompareCT.gov

Clinical Study of Intermittent Positive Pressure Breathing (IPPB)

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Apr 14, 2016

In Brief

A Phase 3 clinical trial evaluating intermittent positive-pressure breathing for Lung Diseases and 2 related conditions. Completed.

Detailed Summary

To evaluate the efficacy of long-term intermittent positive pressure breathing (IPPB) treatment when used as an adjunct to the overall care of ambulatory outpatients with chronic obstructive pulmonary disease. The evaluation compared the use of IPPB with use of a powered nebulizer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Diseases, Lung Diseases, Obstructive, Chronic Obstructive Pulmonary Disease
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
1976197719781979198019811982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartNov 1, 1976
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

intermittent positive-pressure breathingprocedure